Clinical Trials | December 08, 2021
Redcliffe Labs chalks out aggressive expansion plans
It plans to add over 1000 employees over the next six months
It plans to add over 1000 employees over the next six months
SPARC will be eligible to receive an upfront payment, milestone payments and royalty on sales, in addition to 10% equity in Visiox
This is the fourth facility from the company to receive this registration
Healtherbs helps in restoring the desired energy levels for daily activity and immunity
A Care network is a digital health network that connects healthcare stakeholders to deliver streamlined care with the patient at the centre of the experience
He has more than 285 publications with 7,600 citations, 80 students have already been awarded Ph. D. degree under his able guidance and 20 postdoctoral associates have worked in his group
Sputnik M is a new member of the Sputnik vaccines family
The event was organized jointly by Oncology Forum and Fortis Cancer Institute, Delhi NCR
As part of the out-licensing deal with Tabuk, Biocon will develop and manufacture the products, and Tabuk will commercialise them
The investigational compound, GZR18, is a novel analogue of glucagon-like peptide-1 (GLP-1), an incretin hormone responsible for many glucoregulatory effects
Subscribe To Our Newsletter & Stay Updated
